keyword
https://read.qxmd.com/read/38606850/interrogating-matrix-stiffness-and-metabolomics-in-pancreatic-ductal-carcinoma-using-an-openable-microfluidic-tumor-on-a-chip
#1
JOURNAL ARTICLE
Michael D Mohan, Neda Latifi, Robert Flick, Craig A Simmons, Edmond W K Young
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense fibrotic stroma that contributes to aggressive tumor biology and therapeutic resistance. Current in vitro PDAC models lack sufficient optical and physical access for fibrous network visualization, in situ mechanical stiffness measurement, and metabolomic profiling. Here, we describe an openable multilayer microfluidic PDAC-on-a-chip platform that consists of pancreatic tumor cells (PTCs) and pancreatic stellate cells (PSCs) embedded in a 3D collagen matrix that mimics the stroma...
April 12, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38581990/the-nanobody-targeting-pd-l1-and-cxcr4-counteracts-pancreatic-stellate-cell-mediated-tumour-progression-by-disrupting-tumour-microenvironment
#2
JOURNAL ARTICLE
Yaxian Li, Yuejiang Zheng, Shuyi Xu, Hai Hu, Liyun Peng, Jianwei Zhu, Mingyuan Wu
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal malignancy worldwide owing to its complex tumour microenvironment and dense physical barriers. Stromal-derived factor-1 (SDF-1), which is abundantly secreted by tumour stromal cells, plays a pivotal role in promoting PDAC growth and metastasis. In this study, we investigated the impact and molecular mechanisms of the anti-PD-L1&CXCR4 bispecific nanobody on the TME and their consequent interference with PDAC progression. We found that blocking the SDF-1/CXCR4 signalling pathway delayed the epithelial-mesenchymal transition in pancreatic cancer cells...
April 5, 2024: International Immunopharmacology
https://read.qxmd.com/read/38570832/proteomic-profiling-of-small-extracellular-vesicles-derived-from-mouse-pancreatic-cancer-and-stellate-cells-role-in-pancreatic-cancer
#3
JOURNAL ARTICLE
Chamini J Perera, Sm Zahid Hosen, Tanzila Khan, Haoyun Fang, Alpha Raj Mekapogu, Zhihong Xu, Marco Falasca, Suresh T Chari, Jeremy S Wilson, Ron Pirola, David W Greening, Minoti V Apte
Small extracellular vesicles (sEVs) are cell-derived vesicles evolving as important elements involved in all stages of cancers. sEVs bear unique protein signatures that may serve as biomarkers. Pancreatic cancer (PC) records a very poor survival rate owing to its late diagnosis and several cancer cell-derived proteins have been reported as candidate biomarkers. However, given the pivotal role played by stellate cells (PSCs, which produce the collagenous stroma in PC), it is essential to also assess PSC-sEV cargo in biomarker discovery...
April 3, 2024: Proteomics
https://read.qxmd.com/read/38522816/targeting-rock2-improves-macromolecular-permeability-in-a-3d-fibrotic-pancreatic-cancer-microenvironment-model
#4
JOURNAL ARTICLE
Hiroyoshi Y Tanaka, Takuya Nakazawa, Takuya Miyazaki, Horacio Cabral, Atsushi Masamune, Mitsunobu R Kano
Pancreatic cancer is characterized by a densely fibrotic stroma. The fibrotic stroma hinders the intratumoral penetration of nanomedicine and diminishes therapeutic efficacy. Fibrosis is characterized by an abnormal organization of extracellular matrix (ECM) components, namely the abnormal deposition and/or orientation of collagen and fibronectin. Abnormal ECM organization is chiefly driven by pathological signaling in pancreatic stellate cells (PSCs), the main cell type involved in fibrogenesis. However, whether targeting signaling pathways involved in abnormal ECM organization improves the intratumoral penetration of nanomedicines is unknown...
March 22, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38500662/the-tgf-%C3%AE-superfamily-as-potential-therapeutic-targets-in-pancreatic-cancer
#5
REVIEW
Rachel R Tindall, Jennifer M Bailey-Lundberg, Yanna Cao, Tien C Ko
The transforming growth factor (TGF)-β superfamily has important physiologic roles and is dysregulated in many pathologic processes, including pancreatic cancer. Pancreatic cancer is one of the most lethal cancer diagnoses, and current therapies are largely ineffective due to tumor resistance and late-stage diagnosis with poor prognosis. Recent efforts are focused on the potential of immunotherapies in improving therapeutic results for patients with pancreatic cancer, among which TGF-β has been identified as a promising target...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38494151/biodistribution-and-therapeutic-efficacy-of-a-gold-nanoparticle-based-targeted-drug-delivery-system-against-pancreatic-cancer
#6
JOURNAL ARTICLE
Chandra Kumar Elechalawar, Suresh Kumar Gulla, Ram Vinod Roy, Nicolas Means, Yushan Zhang, Sima Asifa, David J Robertson, Chao Xu, Resham Bhattacharya, Priyabrata Mukherjee
Pancreatic cancer is characterized by desmoplasia; crosstalk between pancreatic cancer cells (PCCs) and pancreatic stellate cells (PSCs) leads to the deposition of extracellular matrix proteins in the tumor environment resulting in poor vascularity. Targeting either PCCs or PSCs individually has produced mixed results, and there is currently no effective strategy to target both cell types simultaneously. Previously, we demonstrated, through in vitro cell culture experiments, that a specific gold nanoparticle-based nanoformulation containing the anti-EGFR antibody cetuximab (C225) as a targeting agent and gemcitabine as a chemotherapeutic agent effectively targets both PCCs and PSCs simultaneously...
March 15, 2024: Cancer Letters
https://read.qxmd.com/read/38489997/synthesis-and-biological-activity-of-11-oxygenated-and-heterocyclic-estrone-analogs-in-pancreatic-cancer-monolayers-and-3d-spheroids
#7
JOURNAL ARTICLE
Khaled Alseud, Trevor Ostlund, Mikhail Durymanov, Joshua Reineke, Fathi Halaweish
Pancreatic Ductal Adenocarcinoma (PDAC), representing over 90 % of pancreatic cancer diagnoses, is an aggressive disease with survivability among the worst of all cancers due to its difficulty in detection and its high metastatic properties. Current therapies for PDAC show limited success at extending life expectancies, primarily due to cancer resistance and lack of patient-specific targeted therapies. This work highlights the design and evaluation of estrone-derived analogs with both heterocyclic side-chain functionality and 11-oxygenated functionality for use in pancreatic cancer...
March 5, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38483920/reactive-oxygen-species-responsive-nanoparticles-toward-extracellular-matrix-normalization-for-pancreatic-fibrosis-regression
#8
JOURNAL ARTICLE
Liang Qi, Bo-Wen Duan, Hui Wang, Yan-Jun Liu, Han Han, Meng-Meng Han, Lei Xing, Hu-Lin Jiang, Stephen J Pandol, Ling Li
Pancreatic fibrosis (PF) is primarily characterized by aberrant production and degradation modes of extracellular matrix (ECM) components, resulting from the activation of pancreatic stellate cells (PSCs) and the pathological cross-linking of ECM mediated by lysyl oxidase (LOX) family members. The excessively deposited ECM increases matrix stiffness, and the over-accumulated reactive oxygen species (ROS) induces oxidative stress, which further stimulates the continuous activation of PSCs and advancing PF; challenging the strategy toward normalizing ECM homeostasis for the regression of PF...
March 14, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38479555/comp-promotes-pancreatic-fibrosis-by-activating-pancreatic-stellate-cells-through-cd36-erk-akt-signaling-pathways
#9
JOURNAL ARTICLE
Yi Wang, Hai-Tao Li, Gang Liu, Chuan-Shen Jiang, Yan-Hong Ni, Jing-Hui Zeng, Xia Lin, Qing-Yun Wang, Da-Zhou Li, Wen Wang, Xiang-Peng Zeng
BACKGROUND: Pancreatic fibrosis is one of the most important pathological features of chronic pancreatitis (CP) and pancreatic stellate cells (PSCs) are the key cells of fibrosis. As an extracellular matrix (ECM) glycoprotein, cartilage oligomeric matrix protein (COMP) is critical for collagen assembly and ECM stability and recent studies showed that COMP exert promoting fibrosis effect in the skin, lungs and liver. However, the role of COMP in activation of PSCs and pancreatic fibrosis remain unclear...
March 11, 2024: Cellular Signalling
https://read.qxmd.com/read/38473413/pancreatic-cancer-treatment-targeting-the-hgf-c-met-pathway-the-mek-inhibitor-trametinib
#10
REVIEW
Junyeol Kim, Tae Seung Lee, Myeong Hwan Lee, In Rae Cho, Ji Kon Ryu, Yong-Tae Kim, Sang Hyub Lee, Woo Hyun Paik
Pancreatic cancer is characterized by fibrosis/desmoplasia in the tumor microenvironment, which is primarily mediated by pancreatic stellate cells and cancer-associated fibroblasts. HGF/c-MET signaling, which is instrumental in embryonic development and wound healing, is also implicated for its mitogenic and motogenic properties. In pancreatic cancer, this pathway, along with its downstream signaling pathways, is associated with disease progression, prognosis, metastasis, chemoresistance, and other tumor-related factors...
March 5, 2024: Cancers
https://read.qxmd.com/read/38454609/diabetes-as-a-pancreatic-microvascular-disease-a-pericytic-perspective
#11
REVIEW
Luciana Mateus Gonçalves, Catarina Andrade Barboza, Joana Almaça
Diabetes is not only an endocrine but also a vascular disease. Vascular defects are usually seen as consequence of diabetes. However, at the level of the pancreatic islet, vascular alterations have been described before symptom onset. Importantly, the cellular and molecular mechanisms underlying these early vascular defects have not been identified, neither how these could impact the function of islet endocrine cells. In this review, we will discuss the possibility that dysfunction of the mural cells of the microvasculature-known as pericytes-underlies vascular defects observed in islets in pre-symptomatic stages...
March 7, 2024: Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society
https://read.qxmd.com/read/38451123/review-article-pathogenesis-of-masld-and-mash-role-of-insulin-resistance-and-lipotoxicity
#12
JOURNAL ARTICLE
Shalini K Bansal, Meena B Bansal
BACKGROUND: Insulin resistance and lipotoxicity are extremely interconnected but fundamental in setting the stage for the development of MASLD/MASH. AIM/METHODS: A comprehensive literature search was performed and key themes were synthesised to provide insight into the underlying molecular mechanisms of insulin resistance and lipotoxicity in the liver, muscle, pancreas and adipose tissue and how organ cross-talk is fundamental to driving disease pathogenesis. RESULTS: Classical thinking postulates that excess FFA load exceeds the storage capacity of adipose tissue, which is predicated upon both genetic and environmental factors...
March 7, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38418753/itgb6-promotes-pancreatic-fibrosis-and-aggravates-the-malignant-process-of-pancreatic-cancer-via-jak2-stat3-signaling-pathway
#13
JOURNAL ARTICLE
Yu Zhang, Zhiyuan Chen, Zhengchao Shen, Daohai Qian, Guannan Wang, Xu Wang, Shihang Xi, Xiaoming Wang
Integrin β6 (ITGB6) is upregulated in multiple tumor types and elevated ITGB6 levels have been detected in patients with chronic pancreatitis. However, the role of ITGB6 in pancreatic fibrosis and cancer remains to be elucidated. In the present study, ITGB6 expression was assessed using western blotting and qRT-PCR. Besides, cell proliferation, cycling, migration, and invasion were evaluated using CCK-8, flow cytometry, wound healing, and transwell assays, respectively. The expression of fibrosis and JAK2/STAT3 signaling markers was detected by western blotting and immunofluorescence analysis...
February 28, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38417121/disruption-of-super-enhancers-in-activated-pancreatic-stellate-cells-facilitates-chemotherapy-and-immunotherapy-in-pancreatic-cancer
#14
JOURNAL ARTICLE
Yazhou Wang, Kai Chen, Gang Liu, Chong Du, Zhaoxia Cheng, Dan Wei, Fenfen Li, Chen Li, Yinmo Yang, Ying Zhao, Guangjun Nie
One major obstacle in the drug treatment of pancreatic ductal adenocarcinoma (PDAC) is its highly fibrotic tumor microenvironment, which is replete with activated pancreatic stellate cells (a-PSCs). These a-PSCs generate abundant extracellular matrix and secrete various cytokines to form biophysical and biochemical barriers, impeding drug access to tumor tissues. Therefore, it is imperative to develop a strategy for reversing PSC activation and thereby removing the barriers to facilitate PDAC drug treatment...
February 28, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38414585/nicotinamide-adenine-dinucleotide-phosphate-oxidase-in-pancreatic-diseases-mechanisms-and-future-perspectives
#15
REVIEW
Ya-Wei Bi, Long-Song Li, Nan Ru, Bo Zhang, Xiao Lei
Pancreatitis and pancreatic cancer (PC) stand as the most worrisome ailments affecting the pancreas. Researchers have dedicated efforts to unraveling the mechanisms underlying these diseases, yet their true nature continues to elude their grasp. Within this realm, oxidative stress is often believed to play a causal and contributory role in the development of pancreatitis and PC. Excessive accumulation of reactive oxygen species (ROS) can cause oxidative stress, and the key enzyme responsible for inducing ROS production in cells is nicotinamide adenine dinucleotide phosphate hydrogen oxides (NOX)...
February 7, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38407484/chronic-exposure-to-bde-47-aggravates-acute-pancreatitis-and-chronic-pancreatitis-by-promoting-acinar-cell-apoptosis-and-inflammation
#16
JOURNAL ARTICLE
Xiaoyan Qi, Qiong Liu, Zuxing Wei, Xuyang Hou, Yuhong Jiang, Yin Sun, Shu Xu, Leping Yang, Jun He, Kuijie Liu
The effect of 2,2',4,4'-Tetrabromodiphenyl ether (BDE-47), a persistent environmental pollutant commonly used as a flame retardant in various consumer products, on pancreatitis has not been clearly elucidated, although it has been reported to be toxic to the liver, nervous system, and reproductive system. Acute pancreatitis (AP) and chronic pancreatitis (CP) models were induced in this study by intraperitoneal injection of caerulein. The aim was to investigate the impact of BDE-47 on pancreatitis by exposing the animals to acute (1 week) or chronic (8 weeks) doses of BDE-47 (30 mg/kg in the low-concentration group and 100 mg/kg in the high-concentration group)...
February 24, 2024: Toxicological Sciences: An Official Journal of the Society of Toxicology
https://read.qxmd.com/read/38367466/pirfenidone-alleviates-chronic-pancreatitis-via-suppressing-the-activation-of-pancreatic-stellate-cells-and-the-m1-polarization-of-macrophages
#17
JOURNAL ARTICLE
Hong-Lei Guo, Xue-Song Liang, Xiang-Peng Zeng, Yu Liu, Zhao-Shen Li, Li-Juan Wang, Liang-Hao Hu
In the realm of fibroinflammatory conditions, chronic pancreatitis (CP) stands out as a particularly challenging ailment, lacking a dedicated, approved treatment. The potential of Pirfenidone (PFD), a drug originally used for treating idiopathic pulmonary fibrosis (IPF), in addressing CP's fibrotic aspects has sparked new interest. This investigation focused on the role of PFD in diminishing fibrosis and immune response in CP, using a mouse model induced by caerulein. The research extended to in vitro studies examining the influence of PFD on pancreatic stellate cells' (PSCs) behavior and the polarization of macrophages into M1 and M2 types...
February 16, 2024: International Immunopharmacology
https://read.qxmd.com/read/38333216/corrigendum-arachidonate-15-lipoxygenase-mediated-production-of-resolvin-d5-n-3-dpa-abrogates-pancreatic-stellate-cell-induced-cancer-cell-invasion
#18
Gabriel A Aguirre, Michelle R Goulart, Barts Pancreas Tissue Bank, Jesmond Dalli, Hemant M Kocher
[This corrects the article DOI: 10.3389/fimmu.2023.1248547.].
2024: Frontiers in Immunology
https://read.qxmd.com/read/38327154/chemotherapy-assessment-in-advanced-multicellular-3d-models-of-pancreatic-cancer-unravelling-the-importance-of-spatiotemporal-mimicry-of-the-tumor-microenvironment
#19
JOURNAL ARTICLE
Priyanka Gupta, Camino Bermejo-Rodriguez, Hemant Kocher, Pedro A Pérez-Mancera, Eirini G Velliou
Pancreatic ductal adenocarcinoma (PDAC) is a challenge for global health with very low survival rate and high therapeutic resistance. Hence, advanced preclinical models for treatment screening are of paramount importance. Herein, chemotherapeutic (gemcitabine) assessment on novel (polyurethane) scaffold-based spatially advanced 3D multicellular PDAC models is carried out. Through comprehensive image-based analysis at the protein level, and expression analysis at the mRNA level, the importance of stromal cells is confirmed, primarily activated stellate cells in the chemoresistance of PDAC cells within the models...
February 7, 2024: Advanced biology
https://read.qxmd.com/read/38325667/modulating-pancreatic-cancer-microenvironment-the-efficacy-of-huachansu-in-mouse-models-via-tgf-%C3%AE-smad-pathway
#20
JOURNAL ARTICLE
Yuehui Wang, Arun Zhang, Quanwang Li, Chuanbo Liu
ETHNOPHARMACOLOGICAL RELEVANCE: Huachansu (HCS) is a traditional Chinese medicine obtained from the dried skin glands of Bufo gargarizans and clinical uses of HCS have been approved in China to treat malignant tumors. The traditional Chinese medicine theory states that HCS relieves patients with cancer by promoting blood circulation to remove blood stasis. Clinical observation found that local injection of HCS given to pancreatic cancer patients can significantly inhibit tumor progression and assist in enhancing the efficacy of chemotherapy...
February 5, 2024: Journal of Ethnopharmacology
keyword
keyword
91422
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.